Ductal Carcinoma in Situ (DCIS) News and Research

RSS
Ductal Carcinoma in Situ (DCIS) is a condition where the cells lining the milk ducts (the channels in the breast that carry milk to the nipple) are cancerous, but stay contained within the ducts without growing through into the surrounding breast tissue. DCIS may affect just one area of the breast, but can be more widespread and affect different areas at the same time. Sometimes DCIS may be described as pre-cancerous, pre-invasive, non-invasive, or intraductal cancer.
Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

Study identifies molecular switch that controls fate of milk-producing breast cells

Study identifies molecular switch that controls fate of milk-producing breast cells

Lumpectomy plus radiation associated with reduced risk of breast cancer death, study finds

Lumpectomy plus radiation associated with reduced risk of breast cancer death, study finds

Removing the cancer label - overhaul in cancer classification proposed

Removing the cancer label - overhaul in cancer classification proposed

Study provides insight into how early-stage breast cancer progresses to invasive ductal carcinoma

Study provides insight into how early-stage breast cancer progresses to invasive ductal carcinoma

Surveillance rather than surgery can be safe option for women with FEA lesions

Surveillance rather than surgery can be safe option for women with FEA lesions

Updated guidelines offer support for appropriate, safe use of accelerated partial-breast irradiation

Updated guidelines offer support for appropriate, safe use of accelerated partial-breast irradiation

Study: Major databases provide varying estimates of racial gaps in IBR after mastectomy

Study: Major databases provide varying estimates of racial gaps in IBR after mastectomy

DCIS patients more likely to be alive ten years later than women in general population

DCIS patients more likely to be alive ten years later than women in general population

HER2-targeted dendritic cell vaccine shows promise for treating early-stage breast cancer patients

HER2-targeted dendritic cell vaccine shows promise for treating early-stage breast cancer patients

Radiation boost provides added benefit to DCIS patients following breast-conserving surgery and WBRT

Radiation boost provides added benefit to DCIS patients following breast-conserving surgery and WBRT

ASTRO honors Ms. Keresztes with 2016 Survivor Circle Award

ASTRO honors Ms. Keresztes with 2016 Survivor Circle Award

Delay in radiation therapy increases chances of DCIS recurrence in women

Delay in radiation therapy increases chances of DCIS recurrence in women

New USPSTF breast cancer screening recommendations may result in lethal consequences for women

New USPSTF breast cancer screening recommendations may result in lethal consequences for women

Anastrozole drug effective in treating early form of breast cancer

Anastrozole drug effective in treating early form of breast cancer

APBI brachytherapy improves overall survival in selected patients with early stage breast cancer

APBI brachytherapy improves overall survival in selected patients with early stage breast cancer

Study raises new questions about the best way to treat early cancer cells that define DCIS

Study raises new questions about the best way to treat early cancer cells that define DCIS

Scientists awarded £417,000 to develop a gel to advance breast cancer research, reduce animal testing

Scientists awarded £417,000 to develop a gel to advance breast cancer research, reduce animal testing

Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer

Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer

Researcher study potential biomarker to determine patients at risk for aggressive breast cancer

Researcher study potential biomarker to determine patients at risk for aggressive breast cancer